Cited by 945Cardiovascular Health and Risk FactorsHealth Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.

Lifetime Risks of Cardiovascular Disease

Open access

Berry, Jarett D., Dyer, Alan, Cai, Xuan, Garside, Daniel B., Ning, Hongyan, Thomas, Avis, Greenland, Philip, Van Horn, Linda, Tracy, Russell P., Lloyd-Jones, Donald M.·2012·New England Journal of Medicine

DOI 10.1056/nejmoa1012848PMC PMC3336876

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The lifetime risks of cardiovascular disease have not been reported across the age spectrum in black adults and white adults. METHODS: We conducted a meta-analysis at the individual level using data from 18 cohort studies involving a total of 257,384 black men and women and white men and women whose risk factors for cardiovascular disease were measured at the ages of 45, 55, 65, and 75 years. Blood pressure, cholesterol level, smoking status, and diabetes status were used to stratify participants according to risk factors into five mutually exclusive categories. The remaining lifetime risks of cardiovascular events were estimated for participants in each category at each age, with death free of cardiovascular disease treated as a competing event. RESULTS: We observed marked differences in the lifetime risks of cardiovascular disease across risk-factor strata. Among participants who were 55 years of age, those with an optimal risk-factor profile (total cholesterol level, <180 mg per deciliter [4.7 mmol per liter]; blood pressure, <120 mm Hg systolic and 80 mm Hg diastolic; nonsmoking status; and nondiabetic status) had substantially lower risks of death from cardiovascular disease through the age of 80 years than participants with two or more major risk factors (4.7% vs. 29.6% among men, 6.4% vs. 20.5% among women). Those with an optimal risk-factor profile also had lower lifetime risks of fatal coronary heart disease or nonfatal myocardial infarction (3.6% vs. 37.5% among men, <1% vs. 18.3% among women) and fatal or nonfatal stroke (2.3% vs. 8.3% among men, 5.3% vs. 10.7% among women). Similar trends within risk-factor strata were observed among blacks and whites and across diverse birth cohorts. CONCLUSIONS: Differences in risk-factor burden translate into marked differences in the lifetime risk of cardiovascular disease, and these differences are consistent across race and birth cohorts. (Funded by the National Heart, Lung, and Blood Institute.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1012848

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Self-citation
THE ATHEROSCLEROSIS RISK IN COMMUNIT (ARIC) STUDY: DESIGN AND OBJECTIVES
THE ARIC INVESTIGATORS (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115184 · Cited by 3,510
Untitled work
(1989) · PubMed · Cited by 3,139
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
Design of the Women’s Health Initiative Clinical Trial and Observational Study
The Women’s Health Initiative Study Group (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00078-0 · Cited by 2,580

Flagged first, then by citations

Show all 46 references

Research works printed but not linked: 3

Cohen BB, 1987, Vital Health Stat 1, 22, 1
Cornoni-Huntley J, 1993, Aging (Milano), 5, 27
10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 801–900 of 944

Las tablas de riesgo cardiovascular. Presente y futuro
Cuixart, C. B. (2019) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2019.10.001 · Cited by 1
Discordance between estimated cardiovascular risk and subclinical atherosclerosis in psoriasis: when seeing helps believing
Islam, S. J., & Mehta, A. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa041 · Cited by 1
African ancestry genome-wide association study of blood pressure and hypertension identifies 25 novel loci through predicted gene expressionPreprint
Hellwege, J. N., Liang, J., Giri, A., Keaton, J. M., Sun, X., Torstenson, E. S., Shuey, M. M., Wilson, O. D., Warren, H. R., Arnett, D. K., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1392991/v1 · Cited by 1
Commentary: Using Impedance Cardiography to Detect Asymptomatic Cardiovascular Disease in Prehypertensive Adults with Risk Factors
DeMarzo, A. P. (2018) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0255-2 · Cited by 1
Incremental progress but still far from good enough: real-world LDL-cholesterol insights from the SANTORINI 1-year follow-up study
Dalakoti, M., & Angoulvant, D. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae213 · Cited by 1
Assessment of ten-year cardiovascular disease risk in Bangladesh: A comparative analysis of laboratory and non-laboratory-based WHO risk prediction modelsPreprint
Monower, M. M., Abid, S. U. A., Bhuiyan, M. R., Mamun, M. A. A., & Choudhury, S. R. (2024) · medRxiv · doi:10.1101/2024.07.04.24309982 · Cited by 1
The Four Secrets the Drug Companies Don't Want You to Know
LaMattina, J. L. (2012) · Wiley eBooks · doi:10.1002/9781118511329.ch1
Prevalência da aterosclerose subclínica em mulheres na pós-menopausa com risco cardiovascular baixo e intermediário estimado pelo escore de Framingham
Petisco, A. C. G. P. (2014) · doi:10.11606/t.98.2014.tde-15072014-090843
The Economics of a New Health Technology: An Evaluation of the Impact of Statins on Lifestyle Behaviors
Dehmer, S. P. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)
Stress and Psychological Factors
Höfer, S., Pfaffenberger, N. M., & Kopp, M. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1334-9_10
Relación del fibrinógeno con el riesgo cardiovascular y la mortalidad en una muestra de origen poblacional: estudio de cohortes
Rueda, M. S. (2015) · Biblos-e Archivo (Universidad Autónoma de Madrid)
Дослідження пектинових речовин як адсорбентів ароматичних речовин ефірних олій
Чепель, Н. В., & Грек, О. В. (2014) · ScienceRise · doi:10.15587/2313-8416.2014.26400
Variation in ischaemic heart disease between EU countries
Pinto, F. J. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.116
The Use of Bivalirudin in ST-Segment Elevation Myocardial Infarction
Sergie, Z., Gukathasan, N., Yu, J., & Mehran, R. (2012) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2012.06.003
Protocolo terapéutico de las dislipidemias
Murillo, F. C., & Gallego, R. M. (2013) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(13)70641-3
Reducing lifetime cardiovascular risk
Stock, J. K. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.03.019
Riesgo cardiovascular en pacientes con infección por el virus de la inmunodeficiencia humana en España. Respuesta del autor
Masiá, M., Cachafeiro, S. P., del Amo, J., & Gutiérrez, F. (2013) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2012.12.007
High lifetime risk of cardiovascular disease vs low 10‐year Framingham risk score in HIV‐infected subjects under ART in Spain: the Coronator study
Estrada, V., Masiá, M., Iribarren, J. A., Sánchez, C., Lozano, F., Miralles, C., Olalla, J., Santos, J., Bernardino, J. I., Dronda, F., et al. (2012) · Journal of the International AIDS Society · doi:10.7448/ias.15.6.18109
Características diferenciales del abordaje de la hipertensión en el anciano
Vinyoles, E., de la Figuera, M., & Ferré, J. (2014) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/s1134-2072(14)70691-7
Op naar ‘lifetime’ cardiovasculaire risicobepaling?
de Ruijter, W. (2012) · Huisarts en Wetenschap · doi:10.1007/s12445-012-0177-5
Enfermedades cardiovasculares en España: conclusiones y comentarios finales
Civeira, F. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.11.003
What was new about vascular risk in the year 2012?
Fuentes, D. S., Fernández, C. S., Dalmau, F. G.-B., Prieto, J. M. M., Gutiérrez, P. C., & Cuende, J. I. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2013.09.001
Sex differences in risk factors for coronary artery disease and stroke in men and women aged 45–65 years
Hochner‐Celnikier, D., Chajek‐Shaul, T., & Manor, O. (2013) · Heart Asia · doi:10.1136/heartasia-2013-010258 · Cited by 1
Normal weight is associated with significant reductions in cardiovascular risk for adults, even in those who were overweight or obese as children
Frenn, M. (2012) · Evidence-Based Nursing · doi:10.1136/ebnurs-2012-100628
Beyond Framingham and coronary calcium: Predicted lifetime risk identifies unfavorable risk trajectories
Paixao, A. R. M., & Berry, J. D. (2013) · Journal of Nuclear Cardiology · doi:10.1007/s12350-013-9834-8
Self-citation
Façons d’identifier et de prendre en charge la dyslipidémie athérogène
Bosomworth, N. J. (2013) · Europe PMC (PubMed Central)
Evidence-based screening to prevent and control cardiovascular disease worldwide
Lorenzo, F. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12381
Un programme de réadaptation cardiorespiratoire dans le suivi de l'activité physique chez les gens en prévention primaire et secondaire d'une maladie cardiovasculaire
Levasseur, F. (2014) · Depositum (Université du Québec en Abitibi-Témiscamingue)
6PRNLQJDQG$VVRFLDWHG)DFWRUV$PRQJWKH3RSXODWLRQ$JHG 40-64 in Shahroud, Iran
Hamrah, M. S., Hirosawa, T., Hashemi, H., & Fotouhi, A. (2013)
Srce i krvni Sudovi
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Predicción del riesgo de Enfermedad Cardiovascular en la mujer: ¿Qué papel tienen los nuevos biomarcadores? Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?
Paynter, N. P., Everett, B. M., & Cook, N. R. (2014)
Coming of age with maintained cardiovascular health
Luft, F. C. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.09.002
Impact of renal sympathetic denervation on home blood pressure monitoring in well defined patients with resistant hypertension
Franzen, K. F., Reppel, M., Neuwirth, M. G., Köster, J., Graf, T., Bode, F., Weil, J., & Mortensen, K. (2015) · Clinical Trials and Regulatory Science in Cardiology · doi:10.1016/j.ctrsc.2015.09.005
Risk factor burden in midlife: is it water under the bridge?
Darden, D. J., & Berry, J. D. (2015) · Heart · doi:10.1136/heartjnl-2015-308140
Self-citation
Fatores de Risco Cardiovascular: Influência na capacidade funcional de doentes em Programa de Reabilitação Cardíaca
Branco, C. F. B. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/3fr7-9502
Riesgo coronario en alopecia androgenética
Tavitas, M. E., Morales, M., Pedrero, M. L. P., & Cruz, F. J. (2014) · Revista del Centro Dermatológico Pascua
The effect of moderate preterm birth on an immature cardiovascular system
Nguyen, V. (2017) · Figshare · doi:10.4225/03/58b8bc2cc09a5
The New England Journal of Medicine, CorSalud and Cardiovascular Disease
Moreno, F. L. (2016)
Estimation of cardiovascular risk using 10-year risk metric
Kalhan, A., & Rees, A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835529b6
The New England Journal of Medicine, CorSalud y las enfermedades cardiovasculares The New England Journal of Medicine, CorSalud and Cardiovascular Disease
Moreno, F. L. (2015)
[Hereditary angioedema in organs of the head and neck as an indication for emergency tracheotomy].
Mitrović, S., Jovićević, J., Jović, R. M., & Mitić, I. (2001) · PubMed
Promoting Cardiovascular Health in Men
Mendoza, M., & Loo-Gross, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-26091-4_8
What Is the Significance of Masked Hypertension Versus Incident Hypertension in Blacks?
Franklin, S. S., Rader, F., & Victor, R. G. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06990
Clinical Research Cardiovascular Risk Factors and In-hospital Mortality in Acute Coronary Syndromes: Insights From the Canadian Global Registry of Acute Coronary Events
Wang, J. Y., Goodman, S. G., Saltzman, I., Wong, G. C., Huynh, T. T., Déry, J., Leiter, L. A., Bhatt, D. L., Welsh, R. C., Spencer, F. A., et al. (2015)
Südame isheemiatõve riski ennustamine geneetiliste markerite abil
Saar, A., Marandi, T., Alver, M., Ainla, T., Fischer, K., & Eha, J. (2015) · Ajakirjad. Journals by UT · doi:10.15157/ea.v0i0.12342
Façons d’identifier et de prendre en charge la dyslipidémie athérogène
Bosomworth, N. J. (2013) · Canadian Family Physician
Lipidsenkende Therapie bei geriatrischen Patienten
Lechleitner, M. (2013) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-013-0516-6
Biomarkers and prediction models for type 2 diabetes and diabetes related outcomes
Abbasi, A. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Heart-Healthy Diet
Sivasankaran, S. (2013) · CRC Press eBooks · doi:10.1201/b14663-20
Epidemiology of Aging: Racial/Ethnic Specific Disease Prevalence
Mulvahill, J. S., & Cummings‐Vaughn, L. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-16558-5_8
Genomic Causes of Sudden Cardiac Arrest
Kher, A., Griffith, R. F., & Murray, M. F. (2016) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000474
Use of a genetic risk score to predict adverse events post myocardial infarction and age of first myocardial infarction
Labos, C. (2014) · eScholarship@McGill (McGill) · doi:10.82308/49679
The associations among depression, social support and racial/ethnic disparities in cardiovascular risk profile membership in the National health and nutritional examination survey: a latent profile analysis
Johnson, A. J. (2016) · NC Digital Online Collection of Knowledge and Scholarship (The University of North Carolina at Greensboro)
Peer Intervention To Increase Physical Activity Among Working Women
Rowland, S. A. (2017) · DigitalCommons@UNMC
Lifetime Cardiovascular Risk: The More Things Change . . .
Krumholz, H. M., & Sm (2012) · Journal watch · doi:10.1056/jc201201250000003
Factores de riesgo cardiovascular en una población laboral
Casas, X. C., Sancán-Moreira, M. T., & Loor-Mera, L. R. (2017) · Polo del Conocimiento · doi:10.23857/pc.v2i5.182
HIGH SENSITIVITY CARDIAC TROPONIN-T IS ASSOCIATED WITH INCIDENT HYPERTENSION
McEvoy, J. W. (2015)
Das Herz im Alter
Jost, C. A., Müller, P. F., Bertel, O., Naegeli, B., Scharf, C., Wenaweser, P., & Amann, F. W. (2018) · Praxis · doi:10.1024/1661-8157/a003039
Translational Characterization of Arachidonic Acid Metabolism in Vascular Inflammation and Cardiovascular Disease
Schuck, R. N. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/v1fp-bd79
Life Expectancy and Cardiovascular Mortality in Europe
de Werf, F. V. (2019) · THE BANGKOK MEDICAL JOURNAL · doi:10.31524/bkkmedj.2019.09.016
Diagnosing using Western medicine methods
Al-Shura, A. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817572-9.00014-8
Cardiovascular Risk Prediction in Patients With HIV Infection
Τζιόμαλος, Κ. (2019) · Future Virology · doi:10.2217/fvl-2019-0131
Factores de riesgo cardiovascular y periodontitis
Bermejo, J. A. S. (2019) · doi:10.14201/gredos.140523
Hart- en vaatziekten
Rouwet, E. V., & Hofstra, L. (2020) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2324-1_5
Risk Assessment in CVD
Dörr, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-38647-4_4
Is the total cardiovascular risk of hypertensive patients higher than the amount of individual risks of the involved factors?
Disciplina Medicina de familie, U. D. M. Ş. F. „. D., Bejan, G. C., Stănescu, A. M. A., Disciplina Medicina de familie, U. D. M. Ş. F. „. D., Ghilencea, L. N., Disciplina Medicina de familie, U. D. M. Ş. F. „. D., Iancu, M. A., Disciplina Medicina de familie, U. D. M. Ş. F. „. D., Ștefani, C., Disciplina Medicina de familie, U. D. M. Ş. F. „. D., et al. (2019) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2019.1.11
ICU and the elderly
Keays, R. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-7020-4762-6.00012-6
Nurse-Led Behaviour Change Interventions to Improve Medication Adherence in Patients with Cardiovascular Disease
Al‐Ganmi, A. H. A. (2020) · UTS ePRESS (University of Technology Sydney)
Primary Prevention of Coronary Artery Disease
Sharma, K., Rubenfire, M., & Bates, E. (2020) · Springer eBooks · doi:10.1007/978-3-030-28328-5_6
WITHDRAWN: Studying of some biochemical parameters are related to heart diseases patients in Diyala province
Qaddoori, H. T., Majeed, M. I., & Al-shoky, M. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.03.529
Retracted
Short-Term Resting-State Heart Rate Variability
Liou (2020) · Nova Science Publishers eBooks · doi:10.52305/syai4000
Defining Cardiovascular Dysfunction in the Metabolic Syndrome: therapeutic and nutritional approaches to treatment
Fournier, S. (2015) · doi:10.33915/etd.5614
Associação de placas carotídeas e do espessamento médio-intimal da carótida comum, avaliados ultrassonograficamente, com fatores de risco cardiovascular tradicionais no estudo de saúde longitudinal do adulto (ELSA-Brasil)
Neto, P. J. D. S. (2021) · doi:10.11606/t.5.2021.tde-19082021-112516
Dislipidemias: terapêutica atual e perspectivas futuras na redução de riscos cardiovasculares
Lopes, M. G., & Sposito, A. C. (2018) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2018.17.3.19-23
Meeting abstracts from the 2020 UCD School of Medicine Summer Student Research Awards (SSRA 2020)
(2021) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-021-02718-9
Hypertension management in the COVID-19 era. Getaway from pandemic snares
Wolf, J., & Narkiewicz, K. (2021) · Arterial Hypertension · doi:10.5603/ah.a2021.0024 · Cited by 1
Pictorial presentation of subclinical atherosclerosis : a measure to reduce the risk for cardiovascular disease
Bengtsson, A. (2021)
The state of Oregon : its resources and opportunities; official pamphlet published for the information of homeseekers, settlers and investors
Burke, T. C. (1912)
Prediction of the Population at Risk of Atherothrombotic Disease: A Three Step Approach
Feeman, W. E. (2022) · Cardiology Research and Reports · doi:10.31579/2692-9759/036
Faculty Opinions recommendation of Angiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trial.
Eron, J., & Hurt, C. B. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717962173.793466313
Cardiovascular and Pulmonary Late Effects
Aleman, B. M. P., & Cutter, D. J. (2020) · Hematologic malignancies · doi:10.1007/978-3-030-32482-7_27
Current World Literature
(2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835670af
Epidemiology of Atherosclerotic Vascular Disease
Andersson, C., & O’Donnell, C. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-37393-0_46-1
Hart- en vaatziekten
Rouwet, E. V., & Hofstra, L. (2022) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2761-4_5
Lifetime risks of CVD
(2012) · Nurse Prescribing · doi:10.12968/npre.2012.10.2.101a
O PAPEL DA FISIOTERAPIA CARDIOVASCULAR NA ATENÇÃO PRIMÁRIA À SAÚDE
de Souza, C. G., de Almeida, I. L. G. I., Silva, K. L. S., Vitorino, D. F. D. M., & Costa, H. S. (2022) · Editora Omnis Scietia eBooks · doi:10.47094/978-65-5854-764-8/178-194
Bioactive lipids in cardiovascular disease
Resende, C. X., Amador, A. F., Calvao, J., & Costa, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00001-4
The effectiveness of Telemedicine on Patients after Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Controlled Trials (Preprint)Preprint
Qiu, F., Wei, F., Cai, X., Zhang, G., & Yang, W. (2023) · doi:10.2196/preprints.45621
Self-citation
The Unhappening of Heart Disease
Silverstein, H. (2023) · Medical Research Archives · doi:10.18103/mra.v11i1.3368
Antiplatelet treatment in acute myocardial infarction
Bergmeijer, T. O. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20230530tb
Examination of the Psychometric Properties of the Persian Version of the Challenges to Stopping Smoking Scale (CSS) in Patients with Cardiovascular Disease (CVD).
Mohammadi, S., Fallahi, A., Ebadi, A., & Gheshlagh, R. G. (2023) · PubMed Central
Stable Lipid Management: Standing on Solid Ground
Lee, H. J., & Yoon, H. (2024) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2024.4.e7
Changes in Peripheral Blood Pressure with Normal and Accelerated Aging
Franklin, S. S., & Olsen, M. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15512-3.00034-9
INSTRUMENTOS DE QUALIDADE DE VIDA EM PACIENTES COM ANGINA ESTÁVEL AMBULATORIAL: UMA REVISÃO SISTEMÁTICA
dos Santos, S., Chassot, M. D., Machado, E. D. O., Vizini, S. T., da Rosa, F. S., Michielin, F. D. C., Inchauspe, J. A. F., Santarém, M. D., Wachter, D. A., & Machado, R. A. D. M. (2024) · Editora Científica Digital eBooks · doi:10.37885/240115556
Laboratory diagnostics of lipid metabolism disorders: modern innovations in new Russian and international recommendations
Arabidze, G. G., Puhaeva, A. A., & Pravdivtseva, E. V. (2024) · Laboratory Service · doi:10.17116/labs20241301120
Women in Cardiovascular Genetics and Systems Medicine
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4796-0
Hypertension Management in Developing Countries
Cherfane, M., & Haddad, C. (2023) · Springer eBooks · doi:10.1007/978-3-030-74786-2_2-1 · Cited by 1
Comprehensive Evaluation of Clonal Hematopoiesis and Mosaic Loss of Y Chromosome in Cardiovascular Risk: A Thorough Analysis in prospective studiesPreprint
Fawaz, S., Marti, S., Dufossée, M., Pucheu, Y., Gaufroy, A., Broitman, J., Bidet, A., Soumaré, A., Munsch, G., Tzourio, C., et al. (2024) · eLife · doi:10.7554/elife.96150.1
PERFIL EPIDEMIOLÓGICO DO LABORATÓRIO DE HEMODINÂMICA DO HOSPITAL SÃO LUCAS
Brustolin, L. M., Rodrigues, M. B., Barbosa, R. V., Michelon, I. C., & de Almeida, R. M. D. S. S. A. (2024) · Revista Multidisciplinar do Nordeste Mineiro · doi:10.61164/rmnm.v6i1.2405
Kardiovaskuläre Prävention im Alter
Müller‐Werdan, U., Rosada, A., & Norman, K. (2024) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-024-02355-8

Authors: Berry, J. D., Dyer, A., Cai, X., Garside, D. B., Ning, H., Thomas, A., Greenland, P., Van Horn, L., Tracy, R. P., & Lloyd-Jones, D. M.
Affiliations: Northwestern University (US)
University of Minnesota (US)
University of Vermont (US)
ORCID: Berry, Jarett D.
Dyer, Alan
Cai, Xuan
Garside, Daniel B.
Ning, Hongyan
Greenland, Philip
Tracy, Russell P.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2012-01-26
Volume: 366
Issue: 4
Pages: 321-329
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1012848
PMC: PMC3336876
OpenAlex: W2119984740
Cited by: 945
References: 46
Citations by year: 2026: 25 · 2025: 38 · 2024: 58 · 2023: 60 · 2022: 51 · 2021: 60 · 2020: 70 · 2019: 70 · 2018: 66 · 2017: 57 · 2016: 76 · 2015: 73 · 2014: 80 · 2013: 103 · 2012: 55
FWCI: 63.20
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01wh42124-20-0-0, n01wh32105-27-0-1, n01wh42120-22-0-1, n01wh32106-28-0-1, n01hc085082-026, N01-WH-4-2107, n01hc085081-021, n01wh42125-19-0-1, n01wh32108-30-0-1, n01hc045133-001, n01wh042116-008, n01wh32112-26-0-1, N01-WH-4-2122, n01wh32100-28-0-1, n01hc085079-024, N01-WH-3-2109, n01hc015103-009, n01wh42130-23-0-1, n01wh42123-22-0-1, N01-WH-3-2106, n01wh42108-21-0-1, n01hc085084-005, N01-WH-3-2111, n01wh042114-008, n01wh32118-27-0-1, N01-WH-3-2119, n01hc085085-011, n01hc085083-027, n01wh42110-25-0-0, n01hc085080-026, n01wh42122-22-0-1, N01-WH-4-2126, N01-WH-4-2111, N01-WH-3-2105, N01-WH-3-2100, N01-WH-4-2129, n01wh42131-22-0-1, N01-WH-4-2130, n01wh44221-7-0-1, N01-WH-3-2118, n01wh42129-23-0-1, N01-WH-4-2116, N01-WH-3-2108, N01-WH-4-2110, n01wh42115-19-0-1, n01hc085086-022, N01-WH-3-2101, n01wh32111-28-0-1, n01wh32115-26-0-1, N01 WH 44221, n01wh22110-38-0-0, N01-WH-3-2115, N01-WH-4-2117, N01WH24152, n01wh42132-22-0-1, n01wh42121-21-0-1, n01wh32101-25-0-1, n01wh42111-19-0-1, N01-WH-4-2124, n01wh24152-12-0-0, n01wh42113-23-0-1, N01-WH-4-2131, n01wh32113-30-0-1, N01-WH-4-2113, n01wh42119-25-0-1, N01-WH-4-2109, N01-WH-4-2115, N01-WH-4-2132, N01-WH-3-2112, n01hc55222-0-0-0, N01-WH-4-2121, n01wh42126-26-0-1, n01wh32122-31-0-1, n01wh42118-20-0-1, N01-WH-4-2119, n01wh32119-24-0-1, N01-WH-3-2122, n01wh42107-22-0-1, N01-WH-4-2125, n01wh42109-28-0-1, n01wh042112-013, N01-WH-4-2120, N01-WH-2-2110, n01hc075150-004, n01hc035129-010, N01-WH-4-2114, n01wh42117-21-0-1, n01wh32102-33-0-0, N01-WH-4-2123, N01-WH-4-2118, N01-WH-3-2102, N01-WH-4-2112, N01-WH-4-2108, N01 WH022110, n01wh32109-27-0-1, N01-WH-3-2113)
National Heart, Lung, and Blood Institute (N01-HC-85081, N01HC85085, N01 HC085086, N01HC-85083, N01HC15103, N01 HC085079, N01HC85082, N01HC‐75150, N01 HC85086, R01HL068140, N01HC85080, N01 HC55222, K23HL092229, N01‐HC‐45133, U01HL080295, R01HL043232, R21HL085375, N01-HC85079, N01-HC85084, N01HC35129)
National Center for Research Resources (UL1RR025741)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: lifetime risk, cardiovascular disease, cardiovascular risk factors, racial differences, Black people, White adults, coronary artery disease, myocardial infarction, stroke, blood pressure, cholesterol, smoking, diabetes mellitus, birth cohort, competing risk of death
MeSH terms: Adult, Aged, Black or African American, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Risk, Risk Factors, United States, Cohort Effect, Risk Assessment, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Lifetime Risks of Cardiovascular Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks